Pharmaceuticals for the treatment of agitation; pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, neurodegenerative diseases, alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, or other central nervous system disorders.
WITHDRAWN
on 31 Dec 1969
ALMIQI
BIOXCEL THERAPEUTICS INC.
2113252 · 14 Apr 2021
005
Class 005
Pharmaceutical Products
Pharmaceuticals for the treatment of agitation; pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, neurodegenerative diseases, alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, or other central nervous system disorders.
Pharmaceuticals for the treatment of agitation; pharmaceuticals for th...
